Taking pharmaceutical projects from concept to bankability to execution.

BPI works across three execution tracks.
Projects are financed through a catalytic model blending government equity, donor co-funding, and development finance capital. The pipeline targets manufacturing capacity for IV fluids, ARVs, diagnostics, and oncology and NCD medicines, alongside the regulatory infrastructure and regional distribution networks that underpin that capacity.
As the pipeline grows, BPI continues to build the core team and operating structure needed for investment promotion, partnership development, project financing, and pharmaceutical sector coordination.
